Phase
Condition
Eyelid Inflammation
Blepharitis
Dry Eye Disease
Treatment
Vehicle gel
Testosterone gel 4.5%
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Moderate to severe dry eye (TBUT < 6.0 seconds, corneal staining > grade 1.5,evidence of meibomian gland secretion compromise or Schirmer < 5 mm wetting in 5minutes)
Age over 18
Mild ectropion
Previous contact lens wearers IF no wear for prior 6 months
Punctal plugs if more than three months since placement
Systemic tetracyclines, antihistamines if consistent dosing
Sjogren's syndrome and related autoimmune conditions can be enrolled
Patients using topical dry eye treatments (e.g., Restasis) if willing to discontinuefor 30 days
Exclusion
Exclusion Criteria:
If artificial tears or autologous serum used on day of study
Ocular surgery if less than 12 months
Punctal plugs if within 3 months of plug insertion
Contact Lens wear within the six months prior to study
PSA levels greater than 4 ng/ml or BPH
Recent or current thrombolism
Recent or current cardiovascular events (e.g., MI, stroke)
Recent or current liver disorders
Concurrent use of topical medications; e,g., topical glaucoma medications
Diabetics
Females of child-bearing age if not on reliable birth control
History of breast cancer
Cannot be taking insulin, warfarin or systemic corticosteroids
Study Design
Study Description
Connect with a study center
Southern California College of Optometry at Marshall B. Ketchum University
Fullerton, California 92831
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.